KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Assets Average (2016 - 2025)

Neogenomics' Assets Average history spans 15 years, with the latest figure at $1.4 billion for Q4 2025.

  • For Q4 2025, Assets Average fell 16.61% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, down 16.61%, while the annual FY2025 figure was $1.5 billion, 9.68% down from the prior year.
  • Assets Average reached $1.4 billion in Q4 2025 per NEO's latest filing, down from $1.4 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.9 billion in Q3 2021 to a low of $759.7 million in Q1 2021.
  • Average Assets Average over 5 years is $1.6 billion, with a median of $1.7 billion recorded in 2023.
  • Peak YoY movement for Assets Average: soared 283.59% in 2021, then decreased 16.61% in 2025.
  • A 5-year view of Assets Average shows it stood at $1.9 billion in 2021, then decreased by 7.43% to $1.7 billion in 2022, then dropped by 3.89% to $1.7 billion in 2023, then fell by 2.39% to $1.6 billion in 2024, then fell by 16.61% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for NEO's Assets Average are $1.4 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.5 billion (Q2 2025).